FML welcomes a new spinoff to its ranks
Diaxxo becomes the latest company to be founded by members of the FML research group. It develops point-of-care PCR devices for diagnostics.
external page Diaxxo aims to bring the power of molecular diagnostics to every doctor’s office, thanks to their new device that works with ready-to-use kits in order to make DNA analysis faster and more accessible. The solution is ideal for family doctors and medical centers for the immediate diagnosis of viral and bacterial diseases, such as Sexually Transmitted Infections (STIs). In a clinical study performed last year, the devices were successfully utilized by untrained users to self-test for COVID-19.
